Juan Pasquau, Servicio de Enfermedades Infecciosas. Hospital Universitario Virgen de la Nieves, Granada, Spain.
Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):102-107. doi: 10.37201/req/s03.22.2022. Epub 2022 Oct 24.
The current morbimortality of serious infections is unacceptable and there is a need to promote the increase in the efficacy of empirical and targeted antibiotherapy. This could be achieved by initiatives coming from ASP teams aimed at promoting increased efficacy of antibiotic therapy .In the optimization of the antibiotic therapy there are several critical points in which an adequate timing could achieve benefits in the survival of patients with severe infections: prompt initiation of empirical treatment; de-escalation performance, appropriate targeted treatment; and finally, curtail antibiotic duration.
目前严重感染的发病率和死亡率是不可接受的,需要提高经验性和靶向抗生素治疗的疗效。这可以通过 ASP 团队的举措来实现,旨在提高抗生素治疗的疗效。在优化抗生素治疗中,有几个关键要点,如果时机得当,可以提高严重感染患者的生存率:及时启动经验性治疗;降级治疗、适当的靶向治疗;最后,缩短抗生素使用时间。